Is This News a Setback or a Step Forward for CRISPR Therapeutics?
https://www.fool.com/investing/2023/12/06/is-this-setback-or-step-forward-for-crispr/?source=iedfolrf0000001
Dec 06, 2023 - It's important to look at the news through a long-term lens.
0
CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline
https://www.zacks.com/stock/news/2193794/crispr-crsp-to-focus-on-next-generation-car-t-pipeline?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193794
Dec 05, 2023 - Based on early data from ongoing clinical studies, CRISPR (CRSP) has decided to focus on the development of its next-generation CAR T pipeline and discontinue its first-generation CAR T candidates.
0
The Market's Up This Year. Do You Feel Like You Are Winning?
https://www.fool.com/investing/2023/12/04/the-markets-up-this-year-do-you-feel-like-you-are/?source=iedfolrf0000001
Dec 04, 2023 - We've also got a look at two stocks worth watching and the popular toys for this holiday season.
0
An Important History Lesson for Gene-Editing Investors
https://www.fool.com/investing/2023/12/02/an-important-history-lesson-for-gene-editing-inves/?source=iedfolrf0000001
Dec 02, 2023 - Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.
0